Related Experiment Video
Updated: Feb 11, 2026

Digital Microfluidics for Automated Proteomic Processing
Published on: November 6, 2009
A digital microfluidic system for serological immunoassays in remote settings.
Alphonsus H C Ng1,2, Ryan Fobel1,2, Christian Fobel1,2
1Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
A new portable, point-of-care system using digital microfluidics can rapidly test for disease-specific antibodies from small blood samples. This technology offers a viable solution for serosurveillance in remote areas lacking laboratory access.
Area of Science:
- Biomedical Engineering
- Immunology
- Public Health
Background:
- Serosurveys are crucial for monitoring population immunity to vaccine-preventable diseases.
- Remote populations face significant logistical challenges in accessing centralized laboratory services for serological testing.
- Existing methods require specialized equipment, cold storage, and sample transport, hindering surveillance in resource-limited settings.
Purpose of the Study:
- To develop and validate a compact, field-deployable, point-of-care system for rapid serological testing.
- To assess the analytical performance of a digital microfluidics-based enzyme-linked immunosorbent assay (ELISA) for detecting measles and rubella immunoglobulin G (IgG) antibodies.
- To evaluate the system's utility in a remote refugee camp setting.
Main Methods:
- A point-of-care system utilizing digital microfluidics and inkjet-printed cartridges was developed to perform ELISAs on small capillary blood volumes.
- Field validation was conducted at Kakuma refugee camp, Kenya, testing children and caregivers for measles and rubella IgG antibodies.
- Assay performance was compared against reference ELISAs performed in a centralized laboratory.
Main Results:
- The digital microfluidics system demonstrated high sensitivity and specificity for detecting measles and rubella IgG antibodies in a field setting.
- Measles IgG assay sensitivity was 86% (95% CI, 79-91%) and specificity was 80% (95% CI, 49-94%).
- Rubella IgG assay sensitivity was 81% (95% CI, 73-88%) and specificity was 91% (95% CI, 76-97%).
Conclusions:
- The developed point-of-care digital microfluidics system is a promising tool for global serological surveillance.
- This technology can overcome logistical barriers, enabling effective disease monitoring in remote and underserved populations.
- The system facilitates rapid, on-site antibody testing, improving the timeliness and accessibility of public health data.
Related Concept Videos
Setting Time of Cement
Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
PPE Use in Healthcare Settings I: Donning
PPE Use in Healthcare Settings II: Doffing
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Alternative Sets of Equilibrium Equations
One example of such a situation can be observed in a...

